Abbott Nutrition plans to build a $500 million facility to produce specialty and metabolic infant formulas after having its sole plant producing the products closed earlier this year over contamination concerns. The closure led to a national shortage of infant formula.
Check out RetailWire’s Engaging Online Discussions Featuring Our Exclusive Braintrust!
©2022 RetailWire LLC. All rights reserved.